IGF1 and breast cancer: In summary, this study demonstrates that IGF-1, which is significantly involved in poor prognosis and outcome in women with breast cancer, upregulates Cyr61 through both the MAPK and PI3K/Akt pathways resulting in cell invasion and growth (Figure 6).